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We studied determinants of efficient encapsidation of circular DNA, incorporating a PV early region DNA sequence (nt
584–1978) previously shown to enhance packaging of DNA within papillomavirus (PV)-like particles (VLPs). Insect coelomic
cells (Sf-9) and cultured monkey kidney cells (Cos-1) were transfected with an 8-kb reporter plasmid incorporating the
putative BPV packaging sequence and infected with BPV1 L1 and L2 recombinant baculovirus or vaccinia virus. Heavy (1.34
g/ml) and light (1.30 g/ml) VLPs were produced, and each packaged some of the input plasmid. In light VLPs, truncated
plasmids, which nevertheless incorporated the PV-derived DNA packaging sequence, were more common than full-length
plasmids. Packaging efficiency of the plasmid was estimated at 1 plasmid per 104 VLPs in both Cos-1 and Sf-9 cells. In each
cell type, expression of the BPV1 early region protein E2 in trans doubled the quantity of heavy but not light VLPs and also
increased the packaging efficiency of full-length circular plasmids by threefold in heavy VLPs. The resultant pseudovirions
incorporated significant amounts of E2 protein. Pseudovirions, comprising plasmids packaged within heavy VLPs, mediated
the delivery of packaged plasmid into Cos-1 cells, whereby “infectivity” was blocked by antisera to BPV1 L1, but not antisera
to BPV1 E4. We conclude that (a) packaging of DNA within PV L11L2 pseudovirions is enhanced by BPV1 E2 acting in trans,
(b) E2 may be packaged with the pseudovirion, and (c) E2-mediated enhancement of packaging favors 8-kb plasmid
incorporation over incorporation of shorter DNA sequences. © 2000 Academic PressINTRODUCTION
Papillomaviruses (PVs) are species-specific, epithelio-
tropic, double-stranded DNA viruses. They are nonenvel-
oped, 50- to 60-nm icosahedral structures (Baker et al.,
1991) that are composed of conserved L1 major and less
conserved L2 minor capsid proteins. Studies of DNA
packaging into PV-like particles (VLPs) by our laboratory
(Zhou et al., 1993; Zhao et al., 1998, 1999) and other
laboratories (Roden et al., 1996; Stauffer et al., 1998) have
indicated that the expression of L1 and L2 capsid pro-
teins together are essential for plasmid DNA encapsida-
tion. For other viruses noncapsid proteins are involved in
DNA packaging. For example, a protein (p40) in herpes
simplex virus is strongly linked with the process of DNA
packaging although it is not a major component of the
infectious virus (Rixon et al., 1988). Similarly, bacterio-
phage P22 gene 2 and 3 proteins are required for suc-
cessful DNA packaging during progeny virion assembly
(Casjens and King, 1974, 1975; Casjens et al., 1992). In
PV, five noncapsid proteins (E1, E2, E5, E6, and E7) are
involved in DNA replication. Although DNA packaging
studies in papillomaviruses have been extensively con-
ducted (Zhou et al., 1993; Zhao et al., 1998, 1999; Roden
et al., 1994, 1995, 1996; Unckell et al., 1997; Stauffer et al.,
1998; Touze and Coursaget, 1998; Kawana et al., 1998), it1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 07 3240 2048. E-mail: knzhao@medicine.pa.uq.edu.au.
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
382is not clear whether any PV early protein is involved. The E2
protein of HPV plays a central role in the viral life cycle by
regulating both transcription and replication of the viral
genome (Desaintes et al., 1997). This protein binds to a
palindromic DNA sequence present in several copies in the
regulatory region of all PVs (reviewed by Ham et al., 1991).
E2 also acts, in concert with E1 and cellular replication
factors, in the initiation of viral DNA replication (Ustav and
Stenlund, 1991; Chiang et al., 1992a, b; Del Vecchio et al.,
1992). Bovine papillomavirus (BPV) type 1 has been used as
a model for the study of PV replication, transcription, and
cell transformation (Ustav and Stenlund, 1991; Chiang et al.,
1992a, b; Spalholz et al., 1985) and for the study of plasmid
DNA encapsidation in our laboratory (Zhou et al., 1993;
Zhao et al., 1998, 1999). To improve our understanding of
DNA packaging, we have studied the effects of two early
proteins, E1 and E2, on encapsidation of plasmid by BPV
L1/L2 capsids. We have also estimated the efficiency of
DNA packaging and examined the characteristics of en-
capsidated plasmid DNA in individual VLPs. Finally, we
have investigated the delivery of packaged plasmid medi-
ated by pseudovirions into Cos-1 cells and the neutraliza-
tion of the “infectivity” of pseudovirions by antisera.
RESULTS
E2 increases the numbers of VLPs with encapsidated
plasmidWe have previously demonstrated that packaging of
8-kb circular DNA by PV L1 and L2 proteins produces
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383BPV1 E2 PROTEIN ENHANCES DNA PACKAGING EFFICIENCYpseudovirions in cell culture and was enhanced if a
120-bp sequence from the early region of the PV genome
incorporating parts of the E1 and E2 ORF was provided
in cis, although no entire open reading frame is con-
tained within this sequence (Zhao et al., 1999). To inves-
igate whether PV early proteins E1 and E2 provided in
rans can alter the efficiency of DNA packaging, we first
xamined packaging of the plasmid pSV BPV1DL1/L2 in
os-1 cells infected with BPV L1/L2 recombinant vac-
inia virus (rVV), in the presence or in the absence of E1
nd E2. The plasmid pSV BPV1DL1/L2 (Fig. 1A) is about
kb, comparable to the length of the PV genome, which
ncludes most of the BPV genome except the L1/L2 gene
equence. The presence of the SV40 ori and ColE ori
sequences in the plasmid allows replication in large T
antigen-expressing Cos-1 cells and in bacteria, respec-
tively. Standardized numbers of Cos-1 cells, after trans-
fection with pSV BPV1DL1/L2, were infected at 5 plaque-
forming units (PFU)/cell with BPV L1/L2, E1, and E2 rVVs
using four different combinations: (a) rVV BPV L1/L2
alone, (b) BPV L1/L2 1 BPV E1, (c) BPV L1/L2 1 BPV
1/E2, and (d) BPV L1/L2 1 BPV E2. VLPs were purified
rom a lysate of the infected cells by density gradient
eparation, and plasmid DNA extracted from the VLPs
as used to transform Escherichia coli. The number of
mpicillin-resistant (AmpR1) bacterial colonies was used
s a measure of packaging efficiency of the input plas-
id by the BPV1 capsid proteins (Figs. 2A, 2B, and 2C).
xpression of E1 protein in trans did not affect plasmid
ncapsidation by BPV VLPs (Fig. 2B). When VLPs were
roduced in cells expressing E2 in trans, packaging of
nput plasmid DNA was more efficient in the heavy
LP fraction (fraction 9) (Fig. 2C), which appears to be
ighter than the equivalent peaks in Figs. 2A and 2B.
xpression of E2 protein in trans did not increase the
umbers of AmpR1 colonies in light (1.30 g/ml) VLPs
Fig. 2C), suggesting that E2 protein specifically en-
ances full-length plasmid packaging. The effect of
xpression of E1 and E2 protein in trans on packaging
as similar to that of E2 expression alone (data not
hown).
To confirm the packaging findings in Cos-1 cells using
FIG. 1. Plasmids used for DNA packaging experiments. (A) pSV BPV1
roteins expressed using L1/L2 recombinant vaccinia virus, and (B) pUC
recombinant baculovirus.he BPV1 L1/L2 rVV expression system, we have carried
ut further studies of DNA packaging by BPV capsids in
c
cnother cell type and with another recombinant virus
xpression system. A plasmid, pUC18BPV (nt
84–1978)b-gal (Fig. 1B), suitable for studying DNA pack-
, used as the target plasmid for packaging experiments with PV capsid
(nt 584–1978)b-gal, used as the target plasmid in SF9 cells with L1/L2
FIG. 2. Coexpression of BPV1 E2 protein increases the packaging
efficacy of plasmid pSV BPV1DL1/L2 by BPV1 L1 and L2, expressed
using rVV in Cos-1 cells. Packaging is measured as the number of
ampicillin-resistant colonies obtained by transforming E. coli with DNA
xtracted from VLPs, as described under Materials and Methods.
os-1 cells were transfected with pSV BPV1DL1/L2 and infected with
accinia virus recombinant for (A) BPV1 L1/L2 alone, (B) BPV1 L1/L2 1
PV1 E1, and (C) BPV1 L1/L2 1 BPV1 E2. Data points are the average
f three separate experiments. Fraction 8 corresponds to a density of
.34 g/ml and fraction 20 to 1.30 g/ml. Numbers represent fractions of
sCl gradients from bottom (heavy) to top (light). Note: Data (A) areDL1/L2ited from a previously published paper (Zhao et al., 1998) as the
omparative experiments were conducted at that time.
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384 ZHAO ET AL.aging in insect cells (Sf-9 cells) was constructed, and
recombinant baculovirus was used to express the PV
capsid proteins. The plasmid contains a fragment (nt
1506–1625) of BPV1 recently reported to enhance DNA
package into VLPs (Zhao et al., 1999), while the hr5ori
sequence allows plasmid replication in Sf-9 cells. De-
fined numbers of Sf-9 cells were transfected with this
plasmid and then infected at 5 PFU/cell with recombinant
baculoviruses expressing either BPV L1/L2 alone or BPV
L1/L2 plus BPV E2. Plasmid DNA was extracted from
purified VLPs using the same method as for Cos-1 cells,
and the absolute number of plasmids was measured
within a defined quantity of VLPs using real-time quan-
titative PCR through the detection of the AmpR1 gene
equence as an assay of plasmid numbers. Immunoblots
gainst L1 were used to measure total L1 protein as an
ndicator of VLP numbers. When BPV1 L1/L2 were ex-
ressed without E2, most VLPs obtained were of low
ensity (1.30 g/ml) (Figs. 4A and 6A) and substantial
ncorporation of plasmid containing the AmpR1 gene
as observed. Heavy (1.34 g/ml) VLPs were also ob-
erved, but few of these incorporated DNA that included
n intact AmpR1 gene (Fig. 3A). When E2 protein was
oexpressed with L1 and L2, the absolute amount of L1
rotein in the gradient fractions incorporating heavy
LPs increased substantially (Figs. 4 and 6A), suggest-
ng that more VLPs were packaging 8-kb DNA se-
uences. The amount of AmpR1 detected in the heavier
LPs also increased threefold, indicating that E2 expres-
ion also increased the relative proportion of VLPs pack-
ging plasmid (Figs. 3A and 3B). Expression of E2 protein
n trans did not increase the relative proportion or abso-
ute number of AmpR1 DNA templates in light VLPs (Figs.
A and 3B), further indicating that E2 protein enhances
he packaging of full-length plasmid into heavy VLPs of
PV1. Overall, these results allow the conclusion that E2
nhances 8-kb DNA packaging by a specific interaction
ith a target DNA sequence, specific for circular DNA or
or a BPV1 packaging sequence.
1, L2, and E2 proteins are associated in VLPs
By immunoblotting, we examined the migration in a
ensity gradient of L1, L2, and E2 proteins expressed
sing recombinant BVs in insect cells (Figs. 4A, 4B, and
C) or VVs in mammalian cells (data not shown). The
ajority of the L1 and L2 protein was, as expected, found
n the 1.30 and 1.34 g/ml gradient fractions, which had the
ighest numbers of VLPs visible by electron microscopy.
he largest amount of packaged plasmid was also found
n these fractions. These results confirm that PV L1/L2
LPs prefer to adopt either a heavy 1.34 g/ml configura-
ion or a light 1.30 g/ml configuration, with particles of
ntermediate density not favored. The distribution of L2
rotein across the gradient paralleled that of L1, thus
emonstrating that the different VLP densities were not
N
tue to variation in L2 incorporation into the particles
Figs. 4A and 4B). When E2 was expressed in trans, it
as, surprisingly, found in measurable quantities in all
radient fractions containing significant amounts of VLPs
Fig. 4C). Three bands of immunoreactive E2 protein
ere observed in the density gradient when VLPs were
ssembled from BPV L1/L2 with the coexpression of BPV
2 protein, with the strongest band at 31 kDa and two
aint bands at 48 and 28 kDa, respectively (Fig. 4C).
lthough the BPV1 DNA sequence present in cis in the
lasmid used for packaging experiments in Cos-1 cells
ncluded an intact E2 ORF, no E2 protein was detected in
he CsCl density gradient when VLPs were assembled
rom BPV L1/L2 only (data not shown). The data suggest
hat E2 protein, at least when overexpressed, may be
ncorporated into PV virion in association with DNA and
aise the possibility that smaller amounts of E2 are in-
orporated under physiological conditions. The results
lso suggest that simple association of E2 with DNA is
ot sufficient to enhance packaging of longer sequences
f DNA, as E2 was present in the less heavy VLP frac-
ions.
FIG. 3. Coexpression of E2 protein increases the package efficacy of
plasmid pUC18 BPV(nt 584–1978)b-gal by BPV1 L1 and L2, expressed
sing rBV in SF-9 cells. Packaging is measured as the number of DNA
emplates extracted from VLPs, using real-time quantitative PCR as
escribed under Materials and Methods. SF-9 cells were transfected
ith pUC18 BPV(nt 584–1978)b-gal and infected with baculovirus re-
ombinant for (A) BPV1 L1/L2 alone and (B) BPV1 L1/L2 1 BPV E2. Data
oints are the average of three separate experiments. Fraction 6
orresponds to a density of 1.34 g/ml and fraction 13 to 1.30 g/ml.
umbers represent fractions of CsCl gradients from bottom (heavy) to
op (light).
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385BPV1 E2 PROTEIN ENHANCES DNA PACKAGING EFFICIENCYE2 enhances both the production of L1 protein and
the packaging efficiency of heavy VLPs
We have examined whether E2 affects the expression
of BPV1 L1/L2 in Sf-9 insect cells. Total proteins were
extracted from Sf-9 cells that were infected with BPV1
L1/L2 only or with BPV1 L1/L2 1 BPV1 E2 without plas-
id DNA transfection and used for SDS–PAGE and im-
unoblotting experiments (Fig. 5A). Immunoblotting re-
eals that both L1 and L2 were detected in protein
amples from BPV recombinant baculovirus (rBV)-in-
ected Sf-9 cells. However, L1 and L2 bands in protein
amples prepared from BPV1 L1/L2 1 BPV1 E2-infected
Sf-9 cells were much stronger than those from Sf-9 cells
infected with only BPV1 L1/L2 (Fig. 5A), indicating that E2
in trans enhances the production of L1 and L2 proteins in
Sf-9 cells. Densitometric analysis of BPV1 L1 protein
further reveals that expression of L1 and L2, without E2
in trans, resulted in 152.3 6 70.8 mg of BPV L1 protein
from 2 3 106 Sf-9 cells (Fig. 5B) and 370.7 6 77.1 mg
hen E2 was expressed in cells in trans (Fig. 5B). Im-
munoblotting detected three bands of E2 protein of 28,
31, and 48 kDa in a sample prepared from BPV1 L1/L2 1
BPV1 E2-infected Sf-9 cells, but not from BPV1 L1/L2-
infected Sf-9 cells (Fig. 5A).
Immunoblotting was also used to measure the amount
of L1 protein in the heavy and light fractions of a gradient
prepared from Sf-9 cells infected with BPV rBVs. Expres-
sion of L1 and L2, without E2 in trans, resulted in 1.91 6
FIG. 4. Immunoblots of L1, L2, and E2 proteins in fractions from the CsCl
density gradients prepared as described in the legend to Fig. 3. Numbers
represent fractions of CsCl gradients from bottom (heavy) to top (light),
corresponding to fraction numbers in Figs. 3A and 3B. Labeling with
antibodies against L1 (A) and L2 (B) detected a single band of 55 and 77
kDa, respectively. Labeling with antibody against E2 (C) detected three
bands of 28, 31, and 48 kDa (arrowed). The pUC18 BPV (nt 584–1978)b-
gal-transfected Sf9 cells were infected with (2E2) recombinant baculovi-
rus BPV1 L1/L2 only or (1E2) BPV1 L1/L2 1 BPV1 E2.0.44 mg of BPV L1 protein in heavy VLPs prepared from
3 106 Sf-9 cells (Fig. 6A) and 4.30 6 1.48 mg when E2was expressed in trans (Fig. 6A). No corresponding dif-
erence was seen in the amount of L1 in light VLPs
xpressed with or without E2 (Fig. 6A). Based on the L1
rotein data, and data on the copy number of packaged
lasmids in VLPs, we calculated the number of plasmid
NA templates per microgram of L1 capsid protein.
here were (1.96 6 0.34) 3 106 DNA templates/mg of L1
protein in heavy VLPs assembled without E2 protein
expression in trans and (7.42 6 2.31) 3 106 in light VLPs
(Fig. 6B). With E2 expression in trans, (5.36 6 0.58) 3 106
DNA templates/mg were observed in heavy VLPs and
5.22 6 0.64) 3 106 DNA templates in light VLPs (Fig. 6B).
he data confirmed that E2 allowed preferential packag-
ng of plasmid sequences as longer DNA and hence
hifts the distribution of packaged plasmid DNA from
ight to heavy VLPs.
Assuming that one packaged VLP contains one plas-
id, either full size or truncated, that can produce a DNA
emplate, by using real-time quantitative PCR assay, we
alculated that, without E2 in trans, about 1 of 12,000
eavy VLPs, and 1 of 6000 light VLPs, carries plasmid-
erived DNA (Fig. 6C). When E2 protein was provided in
rans, about 1 of 4000 heavy VLPs carries plasmid-de-
ived DNA, a 3-fold increase, and about 1 of 6000 light
LPs carries plasmid-derived DNA, a result unaltered by
2. Considering that the E2 in trans increases the pro-
uction of L1 protein 2- to 3-fold, overall, expression of
2 protein in trans during BPV VLP assembly in vitro
esults in a 6- to 10-fold increase of incorporation of
lasmid-derived DNA in heavy VLPs.
FIG. 5. Effect of E2 on expression of BPV1 L1/L2 in SF-9 insect cells.
Sf-9 cells without plasmid DNA transfection were infected with BPV1
L1/L2 only or BPV1 L1/L2 1 BPV1 E2. (A) Immunoblots of L1, L2, and E2
proteins extracted from Sf-9 insect cells. Labeling with antibodies
against L1 and L2 detected a single band of 55 and 77 kDa, respec-
tively. Labeling with antibody against E2 detected three bands of 28, 31,
and 48 kDa. (B) Densitometric analysis of BPV1 L1 protein prepared
from 2 3 106 Sf-9 cells infected with BPV rBV. Values in each histogram
are the means of four independent measurements, from two separate
experiments. Vertical bars indicate the standard error of the mean.
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386 ZHAO ET AL.Plasmid sequences are commonly truncated in light
VLPs
Previously, we have observed that truncated plasmid
DNA is common in light VLPs (Zhao et al., 1998). We
wished to confirm whether this observation still applied
FIG. 6. Effect of E2 protein coexpression on plasmid packaging
fficiency by BPV1 L1/L2 in SF-9 insect cells. Efficiency of packaging
as compared for heavy (1.34 g/ml) and light (1.30 g/ml) VLPs, pro-
uced with or without E2. (A) BPV L1 protein extracted from heavy
fraction 5 in Fig. 3A and fraction 6 in Fig. 3B) and light (fraction 12 in
ig. 3A and fraction 13 in Fig. 3B) fractions of a VLP gradient prepared
rom 2 3 106 Sf-9 cells, measured by immunoblotting and densitometric
analysis. (B) DNA templates extracted from heavy and light VLP frac-
tions, expressed as templates per microgram of L1 protein and mea-
sured using real-time quantitative PCR as described under Materials
and Methods. (C) Packaging efficiency expressed as the number of
VLPs per DNA template, assuming that all VLPs contain 360 L1 mole-
cules. Values in each histogram are the means of six independent
measurements, from three separate experiments. Vertical bars indicate
the standard error of the mean.when E2 protein was provided in trans and particularly to
examine the state of a b-gal reporter construct incorpo-ated in the packaged plasmid. Encapsidated DNA from
ight and heavy VLPs was characterized after transfor-
ation of E. coli. DNA extracted from 24 randomly se-
ected colonies derived from each particle population
as analyzed by HindIII digestion and electrophoresis.
he representative results are shown in Figs. 7A and 7B.
he plasmid pUC18BPV (nt 584–1978)b-gal contains two
HindIII sites flanking the b-gal sequence. Eight of 24
heavy particles contained a full-length b-gal sequence
and retained the flanking HindIII sites, with packaging of
the full-length plasmid DNA (7.8 kb, Fig. 7B). Only 1 of 24
light particles had the full-length DNA, with the b-gal
sequence (Fig. 7A). As observed previously (Zhao et al.,
1998), the plasmid DNA extracted from colonies derived
from light VLPs was heterogeneous in size, ranging from
3.5 to 7.8 kb (Fig. 7A), with most truncated plasmids
smaller than 6.6 kb.
We similarly analyzed the BPV sequence (nt 584–1978)
in DNA recovered from pseudovirions produced in Sf-9
cells (Figs. 7C and 7D). Extracted DNA from 24 randomly
FIG. 7. Analysis of packaged plasmids recovered from heavy (1.34
g/ml) and light (1.30 g/ml) VLPs prepared in SF9 cells. Plasmid DNA
was extracted from 10 random clones of bacteria transformed by DNA
extracted from VLPs, digested with HindIII to detect the b-gal gene
sequence (A and B) or XbaI to examine the BPV sequence (nt 584–1978,
C and D), and electrophoresed on 1% agarose gel. (A) 1.30 g/ml VLP
particles, (B) 1.34 g/ml particles, (C) 1.30 g/ml VLP particles, and (D) 1.34
g/ml particles. Lanes 1–10 are the results of randomly selected indi-
vidual colonies used for enzyme restriction analysis. Solid arrows
indicate a clone with the restriction pattern of the input plasmid.
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387BPV1 E2 PROTEIN ENHANCES DNA PACKAGING EFFICIENCYselected colonies derived from each VLP population was
analyzed by XbaI digestion and electrophoresis. Of 24
plasmids from heavy VLPs, 11 contained the BPV se-
quence, with packaging of the full-length plasmid (7.8 kb,
Fig. 7D). In contrast, of 24 plasmids from light VLPs, only
2 contained the full-length plasmid with the BPV se-
quence (Fig. 7C). A high percentage of truncated plas-
mids produced more than two fragments after XbaI di-
estion (Figs. 7C and 7D); truncation of this plasmid
ommonly resulted in a new XbaI site, suggesting that
runcation during packaging is not entirely random.
seudovirions can deliver packaged plasmid
nto Cos-1 cells
To test whether the packaged plasmid DNA could be
elivered by VLPs into cells and whether the b-gal re-
porter gene would be expressed, 10 ml of DNase-di-
gested VLPs was used to infect Cos-1 cells. After 52 h,
cells were fixed and stained for b-gal activity. Cos-1 cells
showing blue, indicative of b-gal activity, were easily
visualized after exposure of the cells to heavy VLPs (Figs.
8A and 8B). The intensity of blue color among b-gal-
stained cells varied from intensive to faint staining (Figs.
8A and 8B), indicating that different b-galactosidase ac-
ivities accumulated in individual Cos-1 cells infected
ith VLPs. Only a few blue cells were visualized when
os-1 cells were infected with light VLPs (data not
hown), in keeping with the commonly truncated plas-
ids in light VLPs and the low packaging efficiency of
ull-length plasmid DNA. At the same time, we used VLPs
repared from Sf-9 cells without DNA transfection to mix
ith plasmid pUC18BPV (nt 584–1978)b-gal and used the
LP–plasmid mixture to infect Cos-1 cells to examine
hether plasmid pUC18BPV (nt 584–1978)b-gal could be
xpressed in Cos-1 cells. As a result, no blue cells were
isualized by X-gal staining, indicating that BPV VLPs
ould not mediate the transfer of unpackaged pUC18BPV
nt 584–1978)b-gal to Cos-1 cells (data not shown).
Moreover, we prepared Hirt DNA from Cos-1 cells
nfected with either heavy or light VLPs. PCR analysis
sing primers specific for b-gal and for BPV nt 584–1978
showed that both b-gal and BPV (nt 584–1978) se-
quences could be found in infected cells (Fig. 9B). Using
b-gal and BPV (nt 584–1978) sequence probes in DNA
Southern blot analysis to quantitate the amount of plas-
mid sequence present, however, showed that while the
BPV (nt 584–1978) sequence was detected in DNA sam-
ples prepared from both heavy and light VLP-infected
Cos-1 cells (Fig. 9A), the b-gal gene sequence could not
be detected in DNA from light VLP-infected Cos-1 cells
(Fig. 9A). This result suggests that there was selective
preservation of the BPV-derived putative packaging se-
quence in the truncated DNA packaged within the light
VLPs, confirming a specific role for this sequence in the
packaging process.
y
tAntisera neutralize the infectivity of BPV1
pseudovirions for Cos-1 cells
PV pseudovirions incorporating the b-gal reporter con-
truct were used to examine neutralization of
seudovirion infectivity for Cos-1 cells by antibodies
gainst BPV1 capsid protein (L1) and the early region
rotein (E4). Pseudovirions were exposed to antisera for
h prior to infection of Cos-1 cells. Antiserum to BPV1 L1
apsid was able to block infectivity of pseudovirions for
os-1 cells, whereas antisera to E4 was not. PCR anal-
FIG. 8. Expression of b-gal after infection of Cos-1 cells with BPV1
seudovirions containing the b-gal reporter construct. Pseudovirions
(1.34 g/ml) were dialyzed against PBS containing Mg21 and Ca21 and
digested with 5 units of DNase at 37°C for 20 min. The DNase-treated
VLP suspension was incubated with Cos-1 cells, plated onto tissue
culture plates, grown for 52 h, and stained with X-gal. Stained cells
were examined and photographed using bright-field microscopy. (A) A
single positive cell following infection at a low multiplicity of infection
and (B) a large number of Cos-1 cells show strong X-gal staining after
infection at a high multiplicity of infection.sis of Hirt DNA from VLP-infected Cos-1 cells confirmed
he neutralization results observed by staining cells for
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388 ZHAO ET AL.b-galactosidase activity (Figs. 10A and 10B). However,
PCR analysis of Hirt DNA from Cos-1 cells infected with
light VLPs, which were exposed to E4 antibody for 1 h,
shows only a band for BPV, not for b-gal (Figs. 10A and
0B, lane 8). This probably results from the truncation of
b-gal from plasmid during its packaging into light VLPs.
DISCUSSION
This study demonstrates, using an in vitro packaging
system in insect and eukaryotic cells, that the efficacy of
packaging of circular plasmid by recombinant BPV1 cap-
sid proteins in in vitro systems is low and that truncation
of the packaged circular plasmid is common. Where
truncation occurs, a putative packaging sequence iden-
tified in previous studies (Zhao et al., 1999) is preferen-
tially preserved when compared with a b-galactosidase
reporter gene. The E2 protein of BPV1, provided in trans,
significantly improves (ca. 6- to 10-fold) the packaging
efficiency of 8-kb plasmid in heavy VLPs, whereas the E1
protein does not. These results shed further light on the
role of PV nonstructural proteins in the assembly of PV
virions in the course of natural infection and have impli-
cations for the development of effective PV neutralization
assays.
Previous studies of PV DNA packaging have demon-
strated that only VLPs assembled with PV L1 and L2
capsid proteins can package the full-length BPV1 ge-
nome (Zhou et al., 1993; Roden et al., 1996). Some DNA
s packaged within virus-like particles comprising L1
lone (Unckell et al., 1997; Zhao et al., 1998; Touze and
oursaget, 1998), and a significant increase in such DNA
ackaging occurs when the L2 protein is also available
Zhao et al., 1998). L2 expression rearranges the distri-
ution of L1 within the nucleus of the cell to protein
ncogenic domains (PODs), which have been proposed
s possible sites of virus assembly (Day et al., 1998). One
eature of in vitro packaging systems for PV, and, to a
uch lesser extent, of PV produced by natural infection,
FIG. 9. Southern blot and PCR analysis of Hirt DNA prepared from
Cos-1 cells infected with either heavy (1.34 g/ml) or light (1.30 g/ml)
pseudovirions prepared in Sf-9 cells. Hirt DNA was examined for a
b-gal-specific sequence and for the putative BPV1-derived packaging
sequence. (A) Southern blot of Hirt DNA and (B) PCR for specific insert.s the production of low-density light VLPs. Light VLPs
re more common if L1 alone is expressed. They com-
t
monly appear empty on electron microscopic examina-
ion (Zhao et al., 1998), though the present study and
revious studies have shown that some DNA is incorpo-
ated with these particles (Zhao et al., 1998; Touze and
oursaget, 1998), albeit of shorter length than that found
n the heavier particles. The DNA packaged in light
articles seems to have a preferred size of ;5 kb, and
he infectivity of light VLPs, measured as successful
ransduction of Cos-1 cells with a reporter plasmid, was
pproximately 40-fold less than the infectivity of heavy
LPs. Thus, it would appear that PV L1 with or without L2
s able to package DNA up to ;5 kb and retain a buoyant
ensity of about 1.30 g/ml. Interestingly, particles of in-
ermediate density do not seem to be produced, at least
hen 8-kb circular DNA is available for packaging, sug-
esting that .5-kb linear DNA cannot be packaged to
roduce intermediate-density particles, and the produc-
ion of heavy particles requires circular DNA, which pre-
umably is packaged in a heavy supercoiled state.
A major finding of the current study is that E2 in trans
ncreases the efficiency of DNA packaging. E2 is a nu-
lear protein containing two domains of relatively high
mino acid conservation (Giri and Yaniv, 1988) and a
arboxy-terminal region responsible for protein dimeriza-
ion and specific DNA binding (Androphy et al., 1987;
ostatni et al., 1988; McBride et al., 1988, 1989a). E2
activates PV DNA transcription by binding as a dimer to
the E2 binding site (E2BS), a conserved sequence
FIG. 10. Neutralization of pseudovirions by BPV-1 specific antibody.
Infection of Cos-1 cells with heavy (1.34 g/ml) or light (1.30 g/ml)
pseudovirions prepared in Sf-9 cells was detected by PCR analysis of
DNA extracted from infected Cos-1 cells for the reporter plasmid b-gal
ene sequence (A) or the putative BPV1-derived packaging sequence
B). Pseudovirions were exposed to antibody against BPV L1 capsid
rotein or to antibody against E4 proteins prior to infection. Lanes: (1)
eavy pseudovirions without antibody; (2) light pseudovirions without
ntibody; (3) heavy pseudovirions with anti-L1 antibody (1:100); (4) light
seudovirions with anti-L1 antibody (1:100); (5) heavy pseudovirions
ith L1 antibody (1:1000); (6) light pseudovirions with L1 antibody
1:1000); (7) heavy pseudovirions with E4 antibody (1:100); (8) light
seudovirions with E4 antibody (1:100); (9) Cos-1 cells transfected withhe relevant plasmid; (10) Cos-1 cells without VLP infection; (11) plas-
id DNA.
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389BPV1 E2 PROTEIN ENHANCES DNA PACKAGING EFFICIENCY(ACCGN4CGGT) (Androphy et al., 1987; McBride et al.,
1989a; Bream et al., 1993) present in multiple copies in
the URR of all sequenced PV genomes. In the present
study, plasmid pSV BPVDL1/L2 contains the 17 specific
E2 binding sites according to the previous report (Li et
al., 1989), and plasmid pUC18BPV(nt 584–1978)b-gal has
wo E2 binding sequences. Therefore, E2 will bind to the
nput plasmid DNA, though it is not possible to determine
hether this binding is responsible for the observed
2-associated increase in DNA packaging in the present
tudy. Expression of L2 causes E2 to relocate with L1 to
he PODs of the cell nucleus (Day et al., 1998). Thus E2
nd L2 together may be involved in the association of L1
ith the circular PV genome. In our system, when E2 is
rovided in trans, an increased number of particles in-
orporate a circular plasmid, supporting a role for E2 in
inking DNA to capsid. Direct physical interaction be-
ween L2 and E2 can be demonstrated using an in vitro
rotein–protein association assay (P. Lambert, personal
ommunication). Thus, the interaction between E2 and
2 may facilitate packaging of supercoiled DNA into PV
LPs. The overexpressed E2 appears in our system to
opurify with the L1 and L2 VLPs in buoyant density
radients, as might be predicted if binding of E2 to L2 or
ackaged DNA is facilitating packaging. E2 is not a
ecognized component of naturally occurring PVs, since
2 is a low-abundance protein in a VLP gradient, making
t difficult to detect in natural PV preparations. E2 expres-
ion has been found during the late stage of the viral life
ycle (Burnett et al., 1990; Ozbun and Meyers, 1998).
ence, in our current system the association of E2 with
NA in VLPs may not be only an artifact of protein
verexpression.
According to the previous reports (McBride et al.,
989b; Rank and Lambert, 1995), the BPV1 E2 open
eading frame encodes three transcriptional regulatory
roteins. The full-length open reading frame encodes a
rotein of 410 amino acids that functions as a transcrip-
ional transactivator (E2TA). Two transcriptional repres-
or proteins, E2TR and E8/E2TR, contain the C-terminal
49 and 204 amino acids, respectively. In the present
xperiments, the plasmid that expressed E2 protein in
f-9 cells gave rise to the E2TR species through internal
TG initiation, but not E8/E2TR. Theoretically, this plas-
id could encode two E2 species; in fact, three bands of
2 proteins have been detected in both VLP fractions
nd total cell extracts. It is not clear where one of the
maller E2 protein species is from in our experiments. It
s possible that one of the two smaller E2 proteins is the
rotease-resistant E2 peptide, which is degraded from
ull-length E2. Dostatni et al. (1988) reported that E2 can
egrade into a protease-resistant core of 33 kDa, similar
o one of the two small peptides detected in the present
xperiment. Therefore, further investigation is required to
erify this possible explanation.
Noncapsid proteins often play a role in DNA packag-ng within viruses. In the bacteriophage T3 DNA pack-
ging system (Shibata et al., 1987; Morita et al., 1994,
995), two noncapsid proteins, the products of genes 18
nd 19 (gp18 and gp19), aid DNA packaging into capsids
y acting as molecular motors to wind the DNA into the
rohead. Such packaging of phage DNA, especially in
itro packaging, is strongly energy-dependent (Hendrix,
978), and the energy required for DNA packaging is
rovided by hydrolysis of ATP. Morita et al. (1994) further
bserved that the DNA packaging system of T3 bacte-
iophage displays an ATPase activity. The T3 gp19 non-
apsid protein has ATP binding activity and three ATP
inding and two Mg21 binding consensus motifs in its
amino acid sequences (Morita et al., 1994, 1995). In
contrast, E2 is not known to have ATPase activity, and the
only PV early protein E1 with ATPase activity, E1 (Sedman
and Stenlund, 1998), was not able, in our model system,
to enhance DNA packaging, either alone or in concert
with E2. Thus, the mechanism of E2 enhancement of
DNA packaging must remain speculative, although the
role of E2 interaction with its consensus binding se-
quence could be further studied with mutant E2 proteins
lacking the DNA binding domain.
To date, in vitro attempts to replicate PV packaging of
DNA are not very efficient—even the most efficient pack-
aging systems apparently incorporate only 1 input plas-
mid per 25,000 particles (Unckell et al., 1997). These
figures contrast with the much higher estimates of the
number of particles that will package short DNA se-
quences in cell-free assembly systems, where up to 40%
of VLPs were high density and were assumed to have
packaged DNA and up to 40% of input DNA was pack-
aged (Touze and Coursaget, 1998). The difference is
perhaps due to a lack of competing cell-derived DNA in
a cell-free system. Particles derived from the cell-free
system transfected target cells with an efficiency of
1:1000 “full” VLPs or 1 in 3000 input VLPs. To assess
packaging efficiency in our system, we developed two
independent assays to assess the efficiency of packag-
ing of HPV DNA by the PV L1 and L2 proteins. An E. coli
transformation assay (Zhao et al., 1998, 1999) allows
detection of packaged replication-competent circular
plasmids that are sufficiently intact to have retained the
antibiotic-resistance gene. Calculations of efficiency of
packaging from this system are dependent on estimates
of the efficiency of DNA extraction from the VLPs and of
bacterial transduction by the input plasmid and are
therefore unlikely to be precise. Real-time quantitative
PCR, as pioneered by Higuchi et al. (1992, 1993), was
therefore adapted for the current study, to obtain more
accurate information about packaging efficacy. This
method detects a specific fragment of the input plasmid
within the AmpR1 gene in the packaged DNA: there is no
requirement for intact or circular DNA. The RT-PCR assay
validated against a series of dilutions of external stan-
dard plasmids of known concentration proved suffi-
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390 ZHAO ET AL.ciently reproducible to allow detection of a 30% change
in input DNA concentration (data not shown). Given the
propensity of PV VLPs to package truncated plasmids,
these methods were complemented by analysis of pack-
aged DNA for specific DNA sequences, including the
BPV1 putative packaging sequence, which was incorpo-
rated into both plasmids, and the b-gal reporter gene.
he current data allow the observation that plasmid
runcation is common in light VLPs, but spare the puta-
ive packaging sequence. However, even heavy VLPs do
ot efficiently package the input plasmid in our system,
ith only 1:4000 VLPs containing the input plasmid, per-
aps reflecting low input plasmid number or inefficient
ranslocation of the input plasmid to the cell nucleus
ollowing lipofection. Alternatively, specific DNA se-
uences within the PV L1 and L2 genes may be required
n cis for efficient packaging or other PV proteins besides
1, E2, L1, or L2 may be required in trans.
One goal for production of PV pseudovirions is the
evelopment of a system for measurement of neutraliza-
ion of papillomavirus by sera from infected or immu-
ized subjects. Notwithstanding the relatively inefficient
ackaging of reporter constructs, the currently described
ystem allows production of sufficient infectious
seudovirions in insect cells to conduct virus neutraliza-
ion assays and to observe transfection efficiencies of 1
ell transfected for 3000 input particles, not dissimilar to
he 1 cell infected for 1000 input heavy particles reported
or VLPs produced in a cell-free system (Touze and
oursaget, 1998). Further studies will address the neu-
ralization of human PV genotypes, using the existing
eporter construct and L1 and L2 proteins from different
PV genotypes to assemble pseudovirions.
MATERIALS AND METHODS
ecombinant vaccinia viruses and baculoviruses
BPV1 L1/L2 (Zhou et al., 1992) rVVs, and BPV1 L1/L2
Rose et al., 1993; Paintsil et al., 1996) rBVs were con-
tructed as described previously. For construction of
PV1 E2 rVV and BPV1 E2 VBV BPV1 E2 gene sequence
nt 2608–3528) was amplified by PCR from BPV1 DNA
ith two oligonucleotides, 59-GCGGATCCATGGAGA-
CAGCATGCGAAC-39 (BPV1 nt 2608–2626) and 59-GCG-
GATCCTCACTGGTTCTTCCTCTGTG-39 39 (BPV1 nt 3528–
3509), which contains BamHI sites (underlined). The E2
PCR product was cut with BamHI and cloned into the
BamHI site of the RK19 plasmid to obtain RK19/BPV E2,
which can express BPV E2 VVV in CV-1 cells. The E2 PCR
product was also cloned into the BamHI site of a bacu-
lovirus transfer vector, PVL1393, to obtain plasmid
PVL1393/BPV E2, which expresses BPV E2 VBV in Sf-9
cells.Construction of recombinant plasmids for packaging
Two plasmids (Figs. 1A and 1B) were used for DNA
packaging experiments in recombinant vaccinia virus
and baculovirus systems, respectively. Plasmid pSV
BPVDL1/L2 (Fig. 1A) used for DNA packaging in the
vaccinia virus system was reported previously (Zhao et
l., 1998). Briefly, pUC18 plasmid was cut with BamHI/
indIII and ligated to a 5436-base fragment with a
amHI/HindIII site (nt 6958–7944/0–4450) of BPV1, which
onstitutes the whole BPV1 genome except L1 and L2, to
btain the pUC18 BPVDL1/L2. Then, pSV2 neo was di-
ested with EcoRI and HindIII, and ligated to the BPV1
enome fragment excised from pUC18BPVDL1/L2 to the
ackaging plasmid pSV BPVDL1/L2 (Fig. 1A). Plasmid
UC18BPV(nt 584–1978)b-gal (Fig. 1B) was constructed
or the DNA packaging experiment in a baculovirus sys-
em. A 3.4-kb fragment of the b-gal gene sequence was
mplified by PCR with two oligonucleotides, 59-TC-
AAGCTTCTCGAGGAACTGAAAAACCAG-39 and 59-TC-
GAAGCTTTTATTTTTGACACCAGACCAACTG-39, that con-
tained HindIII sites (underlined). A pUC18 plasmid
containing hr5 ori was cut with HindIII and the HindIII-
digested PCR product was inserted to produce pUC18
b-gal. Two oligonucleotides, 59-GCTCTAGACTTAATGCT-
TGTGTTTCAGCTC-39 and 59-GCTCTAGACCTGATGCAC-
CTGATTTCAGAC-39, were used to amplify nt 584–1978
from BPV1 by PCR. The PCR product and the pUC18
b-gal plasmid were cut with XbaI and ligated to obtain
the plasmid in Fig. 1B.
DNA transfection and virus infection
Plasmid pSV BPVDL1L2 was used to transfect Cos-1
cells. Cos-1 cells, grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine
serum (FBS, CSL, Victoria, Australia), were brought up to
70% confluence in a monolayer in 150-cm2 flasks. Cells
were washed in OPTI-MEM medium (Gibco, Victoria,
Australia) and transfected with 10 mg of plasmid DNA
sing Lipofectamine, following the instructions provided
y the supplier (Gibco). After transfection, cells contin-
ed to grow in DMEM supplemented with 10% FBS. After
6 h, the transfected cells were infected with rVVs BPV
1/L2 alone, rVVs BPV L1/L2 1 BPV E2, rVVs BPV L1/
2 1 BPV E1, and/or rVVs BPV L1/L2 1 BPV E2/E1.
nfected cells were grown at 37°C for 24 h and then at
2°C for a further 24 h before use in the VLP preparation.
Plasmid pUC18BPV(nt 584–1978)b-gal was used to
ransfect Sf-9 cells using the calcium method. SF-9 cells,
rown in Sf-9 cell medium, were brought up to 95%
onfluence and used for transfection in a monolayer in
50-cm2 flasks. The transfected Sf-9 cells were incu-
bated at 28°C for about 5 h. Then, the transfected cells
were infected with either baculovirus BPV L1L2 alone or
baculovirus BPV L1/L2 1 BPV E2. Infected SF-9 cells
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preparation.
VLP preparations and encapsidated plasmid DNA
extraction
The method for preparation of VLPs from both Cos-1
and Sf-9 cells was described previously (Zhao et al.,
1998, 1999). The prepared VLP suspensions, after being
treated with DNase (Zhao et al., 1998), were used for
extraction of encapsidated plasmid DNA and for the
delivery and neutralization assay of encapsidated plas-
mid by VLPs in Cos-1 cells. Extraction of encapsidated
plasmid DNA from VLPs was also described previously
(Zhao et al., 1998, 1999). Extracted plasmid DNA was
resuspended in TE buffer and used for transformation
and quantitative PCR assay.
Transformation and quantitative PCR assay of
encapsidated plasmid DNA
In the vaccinia virus system, DNA was used to trans-
form 40 ml of E. coli DH-a 5 cells as described previously
Zhao et al., 1998, 1999). The number of antibiotic-resis-
ant colonies was used as a measure of the efficiency of
lasmid DNA packaging. In the baculovirus system, the
eal-time quantitative PCR assay of encapsidated plas-
id DNA was adapted from methods described by Higu-
hi et al. (1992, 1993). Two oligonucleotides, 59-CTGGAT-
GAGGCGGTAAATG-39 (nt 4949–4929) and 59-CGGCTC-
AGATTTATCAGCAA-39 (nt 4864–4885), and a probe
ligonucleotide, 6FAM-CAGGACCACTTCTGCGCTCGGC-
AMRA, were designed from the ampicillin-resistant
ene within plasmid pUC18BPV(nt 584–1978)b-gal and
used for the quantitative PCR assay.
Characterization of encapsidated plasmid DNA
The encapsidated DNA prepared from BPV VLPs as-
sembled in the baculovirus system was used to trans-
form E. coli. Randomly selected colonies were amplified
in ampicillin-containing LB medium overnight. Plasmid
DNA was prepared using the modified plasmid DNA
minipreparation method (Zhou et al., 1993). DNA pellets
were resuspended in TE buffer containing RNase, re-
stricted by HindIII or XbaI, and resolved on 1% agarose
el in TBE buffer.
irt DNA preparation
Cells were grown in DMEM supplemented with 10%
BS. Cos-1 cells, grown up to 95% confluence in mono-
ayer in 25-cm2 flasks, were infected with 100 ml of
dialyzed VLP suspension treated with 5 units of DNase
from both heavy (density of 1.34 g/ml) and light (density of
about 1.30 g/ml) fractions in a CsCl gradient. Infected
cells were grown at 37°C for 48 h before being used for
DNA preparation. Cells were collected, pelleted by cen-trifugation, and resuspended in lysate buffer (10 mM
Tris–HCl, pH 7.5, 10 mM EDTA, and 0.2% Triton X-100).
Plasmid DNA was prepared by the Hirt method (Hirt,
1967) with some modifications (Zhao et al., 1998). The
extracted DNA was digested with a single enzyme
(HindIII or XbaI) and electrophoresed on 1% agarose gel.
The DNA was then blotted onto membrane and probed
with either a 32P-labeled b-gal probe or 32P-labeled BPV
(nt 584–1978) sequence probe. The extracted DNA was
also used for PCR amplification using either the b-gal or
the BPV sequence (nt 584–1978) oligonucleotide de-
scribed above.
Immunoblotting of capsid proteins in VLP fractions
Dialyzed VLP fractions were precipitated with 10 vol of
100% ethanol at 270°C for 4 h, and the protein pellets
were collected by centrifugation at 14,000 rpm for 15 min.
Protein pellets, resuspended in 20 ml of 1X Laemmli
buffer (Laemmli, 1970), were boiled for 5 min, separated
on 10% (w/v) SDS–PAGE gels, and then electrotrans-
ferred onto nitrocellulose membranes (Bio-Rad). Blots
were washed with PBS for 10 min and then blocked in
PBS containing 5% nonfat milk for 1 h. Two polyclonal
antibodies that react with capsid proteins L1 (Dako) and
L2 (Liu et al., 1997) were separately used to probe the
respective capsid proteins. An antibody (kindly provided
by Dr. P. Lambert, University of Wisconsin) against BPV
E2 protein was also used to test for E2 protein expres-
sion. The blots were incubated with anti-rabbit second-
ary antibody (Silenus, Victoria, Australia), conjugated
with horseradish peroxidase, at room temperature for 4 h
and then stained with 3,39-diamino-benzidine tetrahydro-
chloride.
Delivery and neutralization assay of encapsidated
plasmid by VLPs in Cos-1 cells
Ten microliters of VLP suspensions from both heavy
and light fractions was dialyzed against PBS and di-
gested with DNase at 37°C for 30 min. For some exper-
iments, 100 ml of DNase-digested VLP suspensions was
incubated with antibodies against BPV-1 capsid protein
L1 or an early region protein E4 (kindly provided by Dr. J.
Doobar, National Institute for Medical Research, London,
UK), diluted 1:100 or 1:1000 for 1 h. VLPs then were used
to infect Cos-1 cells in a 12-well tissue culture plate. The
VLP-infected Cos-1 cells, after incubation for 48 h, were
fixed for b-gal staining or used for Hirt DNA preparation.
ACKNOWLEDGMENTS
This project was funded in part by CSL Ltd., Merck Ltd., the Queens-
land Cancer Fund, the National Health and Medical Research Council
of Australia, and the Princess Alexandra Hospital Foundation. The
seminal contributions of the late Dr. Jian Zhou to this project are
acknowledged.
CC
C
C
C
D
D
D
G
H
H
H
H
K
L
392 ZHAO ET AL.REFERENCES
Androphy, E. J., Lowy, D. R., and Schiller, J. T. (1987). Bovine papilloma-
virus E2 trans-activating gene product binds to specific sites in
papillomavirus DNA. Nature 325, 70–73.
Baker, T. S., Newcomb, W. W., Olson, N. H., Cowsert, L. M., Olson, C.,
and Brown, J. C. (1991). Structures of bovine and human papilloma-
viruses. Analysis by cryoelectron microscopy and three-dimensional
image reconstruction. Biophys. J. 60, 1445–1456.
Bream, G. L., Ohmstede, C. A., and Phelps, W. C. (1993). Characteriza-
tion of human papillomavirus type 11 E1 and E2 proteins expressed
in insect cells. J. Virol. 67, 2655–2663.
Burnett, S., Strom, A. C., Jareborg, N., Alderborn, A., Dillner, J., Moreno,
L. J., Pettersson, U., and Kiessling, U. (1990). Induction of bovine
papillomavirus E2 gene expression and early region transcription by
cell growth arrest: Correlation with viral DNA amplification and evi-
dence for differential promoter induction. J. Virol. 64, 5529–5541.
asjens, S., and King, J. (1974). P22 morphogenesis. I. Catalytic scaf-
folding protein in capsid assembly. J. Supramol. Struct. 2, 202–224.
asjens, S., and King, J. (1975). Virus assembly. Annu. Rev. Biochem. 44,
555–611.
asjens, S., Sampson, L., Randall, S., Eppler, K., Wu, H., Petri, J. B., and
Schmieger, H. (1992). Molecular genetic analysis of bacteriophage
P22 gene 3 product, a protein involved in the initiation of headful
DNA packaging. J. Mol. Biol. 227, 1086–1099.
hiang, C. M., Dong, G., Broker, T. R., and Chow, L. T. (1992a). Control
of human papillomavirus type 11 origin of replication by the E2 family
of transcription regulatory proteins. J. Virol. 66, 5224–5231.
hiang, C. M., Ustav, M., Stenlund, A., Ho, T. F., Broker, T. R., and Chow,
L. T. (1992b). Viral E1 and E2 proteins support replication of homol-
ogous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci.
USA 89, 5799–5803.
Day, P. M., Roden, R. B., Lowy, D. R., and Schiller, J. T. (1998). The
papillomavirus minor capsid protein, L2, induces localization of the
major capsid protein, L1, and the viral transcription/replication pro-
tein, E2, to PML oncogenic domains. J. Virol. 72, 142–150.
el Vecchio, A. M., Romanczuk, H., Howley, P. M., and Baker, C. C.
(1992). Transient replication of human papillomavirus DNAs. J. Virol.
66, 5949–5958.
esaintes, C., Demeret, C., Goyat, S., Yaniv, M., and Thierry, F. (1997).
Expression of the papillomavirus E2 protein in HeLa cells leads to
apoptosis. EMBO J. 16, 504–514.
ostatni, N., Thierry, F., and Yaniv, M. (1988). A dimer of BPV-1 E2
containing a protease resistant core interacts with its DNA target.
EMBO J. 7, 3807–3816.
iri, I., and Yaniv, M. (1988). Structural and mutational analysis of E2
trans-activating proteins of papillomaviruses reveals three distinct
functional domains. EMBO J. 7, 2823–2829.
am, J., Dostatni, N., Gauthier, J. M., and Yaniv, M. (1991). The papillo-
mavirus E2 protein: A factor with many talents. Trends Biochem. Sci.
16, 440–444.
endrix, R. W. (1978). Symmetry mismatch and DNA packaging in large
bacteriophages. Proc. Natl. Acad. Sci. USA 75, 4779–4783.
Higuchi, R., Dollinger, G., Walsh, P. S., and Griffith, R. (1992). Simulta-
neous amplification and detection of specific DNA sequences. Bio-
technology 10, 413–417.
iguchi, R., Fockler, C., Dollinger, G., and Watson, R. (1993). Kinetic PCR
analysis: Real-time monitoring of DNA amplification reactions. Bio-
technology 11, 1026–1030.
irt, B. (1967). Selective extraction of polyoma DNA from infected
mouse cell cultures. J. Mol. Biol. 26, 365–369.
awana, K., Yoshikawa, H., Taketani, Y., Yoshiike, K., and Kanda, T.
(1998). In vitro construction of pseudovirions of human papillomavi-
rus type 16: Incorporation of plasmid DNA into reassembled L1/L2
capsids. J. Virol. 72, 10298–10300.aemmli, U. K. (1970). Cleavage of structural proteins during the as-
sembly of the head of bacteriophage T4. Nature 227, 680–685.Li, R., Knight, J., Bream, G., Stenlund, A., and Botchan, M. (1989).
Specific recognition nucleotides and their DNA context determine
the affinity of E2 protein for 17 binding sites in the BPV-1 genome.
Genes Dev. 3, 510–526.
Liu, W. J., Gissmann, L., Sun, X. Y., Kanjanahaluethai, A., Muller, M.,
Doorbar, J., and Zhou, J. (1997). Sequence close to the N-terminus of
L2 protein is displayed on the surface of bovine papillomavirus type
1 virions. Virology 227, 474–483.
McBride, A. A., Byrne, J. C., and Howley, P. M. (1989a). E2 polypeptides
encoded by bovine papillomavirus type 1 form dimers through the
common carboxyl-terminal domain: Transactivation is mediated by
the conserved amino-terminal domain. Proc. Natl. Acad. Sci. USA 86,
510–514.
McBride, A. A., Bolen, J. B., and Howley, P. M. (1989b). Phosphorylation
sites of the E2 transcriptional regulatory proteins of bovine papillo-
mavirus type 1. J. Virol. 63, 5076–5085.
McBride, A. A., Schlegel, R., and Howley, P. M. (1988). The carboxy-
terminal domain shared by the bovine papillomavirus E2 transacti-
vator and repressor proteins contains a specific DNA binding activity.
EMBO J. 7, 533–539.
Morita, M., Tasaka, M., and Fujisawa, H. (1994). Analysis of functional
domains of the packaging proteins of bacteriophage T3 by site-
directed mutagenesis. J. Mol. Biol. 235, 248–259.
Morita, M., Tasaka, M., and Fujisawa, H. (1995). Structural and func-
tional domains of the large subunit of the bacteriophage T3 DNA
packaging enzyme: Importance of the C-terminal region in prohead
binding. J. Mol. Biol. 245, 635–644.
Ozbun, M. A., and Meyers, C. (1998). Human papillomavirus type 31b E1
and E2 transcript expression correlates with vegetative viral genome
amplification. Virology 248, 218–230.
Paintsil, J., Muller, M., Picken, M., Gissmann, L., and Zhou, J. (1996).
Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not
required for capsid formation. Virology 223, 238–244.
Rank, N. M., and Lambert, P. F. (1995). Bovine papillomavirus type 1 E2
transcriptional regulators directly bind two cellular transcription fac-
tors, TFIID and TFIIB. J. Virol. 69, 6323–6334.
Rixon, F. J., Cross, A. M., Addison, C., and Preston, V. G. (1988). The
products of herpes simplex virus type 1 gene UL26 which are
involved in DNA packaging are strongly associated with empty but
not with full capsids. J. Gen. Virol. 69(Pt 11), 2879–2891.
Roden, R. B., Greenstone, H. L., Kirnbauer, R., Booy, F. P., Jessie, J., Lowy,
D. R., and Schiller, J. T. (1996). In vitro generation and type-specific
neutralization of a human papillomavirus type 16 virion pseudotype.
J. Virol. 70, 5875–5883.
Roden, R. B., Hubbert, N. L., Kirnbauer, R., Breitburd, F., Lowy, D. R., and
Schiller, J. T. (1995). Papillomavirus L1 capsids agglutinate mouse
erythrocytes through a proteinaceous receptor. J. Virol. 69, 5147–
5151.
Roden, R. B., Weissinger, E. M., Henderson, D. W., Booy, F., Kirnbauer,
R., Mushinski, J. F., Lowy, D. R., and Schiller, J. T. (1994). Neutralization
of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.
J. Virol. 68, 7570–7574.
Rose, R. C., Bonnez, W., Reichman, R. C., and Garcea, R. L. (1993).
Expression of human papillomavirus type 11 L1 protein in insect
cells: In vivo and in vitro assembly of viruslike particles. J. Virol. 67,
1936–1944.
Sedman, J., and Stenlund, A. (1998). The papillomavirus E1 protein
forms a DNA-dependent hexameric complex with ATPase and DNA
helicase activities. J. Virol. 72, 6893–6897.
Shibata, H., Fujisawa, H., and Minagawa, T. (1987). Early events in DNA
packaging in a defined in vitro system of bacteriophage T3. Virology
159, 250–258.
Spalholz, B. A., Yang, Y. C., and Howley, P. M. (1985). Transactivation of
a bovine papilloma virus transcriptional regulatory element by the E2
gene product. Cell 42, 183–191.
Stauffer, Y., Raj, K., Masternak, K., and Beard, P. (1998). Infectious
TZ
393BPV1 E2 PROTEIN ENHANCES DNA PACKAGING EFFICIENCYhuman papillomavirus type 18 pseudovirions. J. Mol. Biol. 283, 529–
536.
ouze, A., and Coursaget, P. (1998). In vitro gene transfer using human
papillomavirus-like particles. Nucleic Acids Res. 26, 1317–1323.
Unckell, F., Streeck, R. E., and Sapp, M. (1997). Generation and neutral-
ization of pseudovirions of human papillomavirus type 33. J. Virol. 71,
2934–2939.
Ustav, M., and Stenlund, A. (1991). Transient replication of BPV-1 re-
quires two viral polypeptides encoded by the E1 and E2 open
reading frames. EMBO J. 10, 449–457.
hao, K. N., Frazer, I. H., Jun, L. W., Williams, M., and Zhou, J. (1999).Nucleotides 1506–1625 of bovine papillomavirus type 1 genome can
enhance DNA packaging by L1/L2 capsids. Virology 259, 211–218.
Zhao, K. N., Sun, X. Y., Frazer, I. H., and Zhou, J. (1998). DNA packaging
by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virol-
ogy 243, 482–491.
Zhou, J., Stenzel, D. J., Sun, X. Y., and Frazer, I. H. (1993). Synthesis and
assembly of infectious bovine papillomavirus particles in vitro. J. Gen.
Virol. 74(Pt 4), 763–768.
Zhou, J., Sun, X. Y., Davies, H., Crawford, L., Park, D., and Frazer, I. H.
(1992). Definition of linear antigenic regions of the HPV16 L1 capsid
protein using synthetic virion-like particles. Virology 189, 592–599.
